News & Articles

Keep up to date with the latest technologies and techniques advancing clinical diagnostics

QIAreach SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, provides accurate and objective results in 2 to 15 minutes

Obtaining two vaccine doses remains the most effective way to ensure protection against the COVID-19 Delta variant

Fewer than one in 20 children with symptomatic COVID-19 experienced symptoms lasting longer than 4 weeks, and almost all children have fully recovered by 8 weeks

Patients with underlying heart problems are more than four times as likely to die from COVID-19

Low-cost device lets consumers check themselves for multiple strains of SARS-CoV-2 at home

Researchers have cataloged for the first time

It is hoped this therapy will be a breakthrough for patients suffering from hereditary transthyretin (ATTR) amyloidosis

The fully automated CN-3000 and CN-6000 Systems bring mid- and high-volume coagulation testing to laboratories

Vaccine aims to combat numerous HIV strains, a key requirement of any vaccine to end the HIV/AIDs epidemic

Dr. Erik Tillman shares his virtual company’s quest to find an effective new life-changing treatment for non-alcoholic steatohepatitis

Nobel prize winning CRISPR technology to be applied in development of genetically engineered animal models

Leading clinical laboratory runs first-ever successful automation of a CRISPR test for high-throughput, using Sherlock’s SARS-CoV-2 process

Scientists at University of Warwick demonstrate that levels of a protein – TPD54 – affect movement of cells

Researchers found that longer dosing intervals led to higher antibody levels and a higher proportion of ‘helper’ T cells

Findings explain higher risk of heart attack in people with diabetes, even after treatment

The multiplex PCR test is capable of screening six SARS-CoV-2 variants including the Delta and Delta Plus variants attributable for a recent surge in global COVID-19 cases

Immune repertoire assays offer high detection rates of malignant clones, empowering researchers to better assess blood cancers